Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethylene Glycol SCHEMBL25256580 | 0.86 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| Triethylene Glycol SCHEMBL25300993 | 0.86 | MEN1 (0.62) | MEN1KMT2ATHRBHTTMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL2266294 | 0.86 | TSHR (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| Triethylene Glycol SCHEMBL2264264 | 0.84 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| Tetraethylene Glycol SCHEMBL2263658 | 0.84 | MEN1 (0.59) | MEN1KMT2ATHRBHTTMAPT | |
| Di(Hydroxyethyl)Ether SCHEMBL9769502 | 0.83 | TSHR (0.58) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL2244270 | 0.83 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL3392777 | 0.83 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1176801 | 0.83 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT | |
| SCHEMBL1034519 | 0.83 | MEN1 (0.56) | MEN1KMT2ATHRBHTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | CLARIANT INTERNATIONAL LTD. (CH) | 2021-09-07 | — | — | US | disclosed |
| US-10888719-B2 | Active substance combination of creatine and/or creatinine and phenoxyethanol | BEIERSDORF AG (DE) | 2021-01-12 | — | — | US | disclosed |
| WO-2020216641-A1 | A HAIR WAX COMPOSITION | BEIERSDORF AG (DE) | 2020-10-29 | — | — | WO | disclosed |
| US-10682534-B2 | Cosmetic preparations containing creatine and/or creatinine and organic thickeners | BEIERSDORF, AG (DE) | 2020-06-16 | — | — | US | disclosed |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | CLARIANT INTERNATIONAL LTD. (CH) | 2019-09-10 | — | — | US | disclosed |
| US-9834635-B2 | Polymers based on arcrylic, methacrylic or ethacrylic amidoalkyl sulfonic acid or salts and carboxyalky acrylate, methacrylate or ethacrylate or oligomers of said carboxy compounds | CLARIANT INTERNATIONAL LTD. (CH) | 2017-12-05 | — | — | US | disclosed |
| US-9693973-B2 | Active substance combination of licochalcone A and phenoxyethanol | BEIERSDORF AG (DE) | 2017-07-04 | — | — | US | disclosed |
| US-9655824-B2 | Use of diphenylmethane derivatives as tyrosinase inhibitors | SYMRISE AG (DE) | 2017-05-23 | — | — | US | disclosed |
| US-9526687-B2 | Polymers based on sulfonic acids, amides and special cross-linking agents | CLARIANT INTERNATIONAL LTD. (CH) | 2016-12-27 | — | — | US | disclosed |
| US-9295626-B2 | Compositions comprising isosorbide monoester and N-hydroxypyridones | CLARIANT INTERNATIONAL LTD. (CH) | 2016-03-29 | — | — | US | disclosed |
| US-20040037797-A1 | Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers | BEIERSDORF AG | 2004-02-26 | — | — | US | disclosed |
| US-6620420-B2 | Cosmetic or dermatological application | BEIERSDORF AG (DE) | 2003-09-16 | — | — | US | disclosed |
| US-20030147928-A1 | Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect | BEIERSDORF AG | 2003-08-07 | — | — | US | disclosed |
| US-20030091605-A1 | Use of alpha-lipoic acid for producing cosmetic or dermatological preparations for regenerating stressed skin, in particular aged skin | BEIERSDORF AG | 2003-05-15 | — | — | US | disclosed |
| US-20030012801-A1 | Active ingredient combinations of surface-active citric esters and inclusion compounds of cyclodextrins and retinoids, and cosmetic and dermatological preparations containing such mixtures | BEIERSDORF AG | 2003-01-16 | — | — | US | disclosed |
| US-20020176832-A1 | O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | CLARIANT INTERNATIONAL LTD. (CH) | 2002-11-28 | — | — | US | disclosed |
| US-20020155076-A1 | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | CLARIANT INTERNATIONAL LTD. (CH) | 2002-10-24 | — | — | US | disclosed |
| US-20020119114-A1 | Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures | BEIERSDORF AKTIENGESELLSCHAFT | 2002-08-29 | — | — | US | disclosed |
| US-6436414-B1 | Active ingredient combinations or adducts of biotin and/or biotin derivatives and cyclodextrins and use of such active ingredient combinations in cosmetic preparations | BEIERSDORF AG (DE) | 2002-08-20 | — | — | US | disclosed |
| US-20020045596-A1 | Active ingredient combinations or adducts of cyclodextrins and at least one quinone and/or at least one hydroquinone and use of such active ingredient combinations in cosmetic preparations | BEIERSDORF AG (DE) | 2002-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020045596-A1 | Active ingredient combinations or adducts of cyclodextrins and at least one quinone and/or at least one hydroquinone and use of such active ingredient combinations in cosmetic preparations | NQO1, RECQL, KEAP1 | MEN1 2565/4885KMT2A 3530/4885THRB 4718/4885 |
| US-10888719-B2 | Active substance combination of creatine and/or creatinine and phenoxyethanol | REN, CKMT1A; CKMT1B, CRAT | MEN1 4090/4885KMT2A 951/4885THRB 2281/4885 |
| US-11110121-B2 | Compositions comprising hydrogen peroxide or hydrogen peroxide donor substances | GPX4, LPO, CAT | MEN1 3224/4885KMT2A 4648/4885THRB 2791/4885 |
| US-20030012801-A1 | Active ingredient combinations of surface-active citric esters and inclusion compounds of cyclodextrins and retinoids, and cosmetic and dermatological preparations containing such mixtures | ALDH1A2, GAA, GCDH | MEN1 3273/4885KMT2A 4662/4885THRB 3309/4885 |
| US-20020176832-A1 | O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | AGPAT2, PHOSPHO1, MBOAT1 | MEN1 4169/4885KMT2A 743/4885THRB 4712/4885 |
| US-20020155076-A1 | Gel creams in the form of O/W emulsions containing one or more ammonium acryloyldimethyltaurate/vinylpyrrolidone copolymers | AGPAT2, ACMSD, POLR1C | MEN1 4477/4885KMT2A 1076/4885THRB 3979/4885 |
| US-20020119114-A1 | Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures | LIPA, GLA, DEGS1 | MEN1 1433/4885KMT2A 2016/4885THRB 2531/4885 |
| US-20030091605-A1 | Use of alpha-lipoic acid for producing cosmetic or dermatological preparations for regenerating stressed skin, in particular aged skin | CUTA, LIPA, LPO | MEN1 4447/4885KMT2A 4069/4885THRB 1573/4885 |
| US-10682534-B2 | Cosmetic preparations containing creatine and/or creatinine and organic thickeners | CKMT1A; CKMT1B, OTC, CRAT | MEN1 3729/4885KMT2A 1333/4885THRB 3985/4885 |
| US-10406135-B2 | Compositions containing isosorbide monoester and alcohols that contain at least one aromatic group | ADH5, ADH1A, ADH1C | MEN1 3537/4885KMT2A 4657/4885THRB 941/4885 |
| US-20030147928-A1 | Water, oil in water emulsifiers, optionally coemulsifiers, oil phase(s), polidocanol and an essential oil; saturated cloth; immediate and long-lasting effect | POLD1, POLD3, POLI | MEN1 4540/4885KMT2A 1719/4885THRB 3807/4885 |
| US-20040037797-A1 | Water-in-oil emulsions containing one or more ammonium acryloylodimethyltaurate/vinylpyrrolidone copolymers | PHOSPHO1, AGPAT2, AGPAT5 | MEN1 3181/4885KMT2A 1398/4885THRB 4419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.